Literature DB >> 27530090

Acute Sinus Node Dysfunction after Atrial Ablation: Incidence, Risk Factors, and Management.

Ammar M Killu1, Erin A Fender1, Abhishek J Deshmukh1, Thomas M Munger1, Philip Araoz2, Peter A Brady1, Yong-Mei Cha1, Douglas L Packer1, Paul A Friedman1, Samuel J Asirvatham1,3, Peter A Noseworthy1, Siva K Mulpuru4.   

Abstract

BACKGROUND: Many patients with atrial fibrillation (AF) or atrial flutter (Aflutter) have concomitant sinus node dysfunction (SND). Ablation may result in injury to the sinus node complex or its blood supply resulting in sinus arrest and need for temporary pacing. We sought to characterize patients who develop acute SND (ASND) during/immediately after AF/Aflutter ablation.
METHODS: We performed a retrospective analysis of AF/Aflutter ablation patients between January 1, 2010 and February 28, 2015 to characterize those who required temporary pacemaker (TPM) implantation due to ASND (sinus arrest, sinus bradycardia <40 beats/min, or junctional rhythm with hemodynamic compromise) following atrial ablation.
RESULTS: Of 2,151 patients, eight patients (<0.5%) with ASND manifesting as sinus arrest (n = 2), severe sinus bradycardia (n = 2), and junctional rhythm with hemodynamic compromise (n = 4) were identified (all male, age 66 ± 9.9 years, 4/8 [50%] persistent AF). AF ablation was performed in four, atypical Aflutter in one, and AF/Aflutter in three patients. The ablation set consisted of: pulmonary vein (PV) isolation (n = 6), roof line ablation (n = 6), mitral annulus-left inferior PV line ablation (n = 5), left atrial appendage-mitral annulus ablation (n = 1), cavotricuspid isthmus ablation (n = 5), and isolation or ablation near the superior vena cava (SVC, n = 4). Patients with peri-SVC ablation were more likely to develop ASND (P = 0.03). All patients received TPM; six received permanent pacemaker before discharge, performed 3.5 days postablation (range 2-6 days). At 3-month device interrogation, all patients were atrially paced >50%.
CONCLUSION: ASND is a rare complication of atrial ablation. It may be more common when peri-SVC ablation is performed and may necessitate permanent pacemaker implantation.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ablation; atrial fibrillation; pacemaker; sinus node dysfunction

Mesh:

Year:  2016        PMID: 27530090     DOI: 10.1111/pace.12934

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  The incidence, indications and predictors of acute pacemaker implantation after ablation of persistent atrial fibrillation.

Authors:  Verena Semmler; Felix von Krogh; Bernhard Haller; Tilko Reents; Felix Bourier; Marta Telishevska; Marc Kottmaier; Marielouise Kornmayer; Stephanie Brooks; Katharina Koch-Büttner; Carsten Lennerz; Amir Brkic; Christian Grebmer; Patrick Blazek; Severin Weigand; Gabriele Hessling; Christof Kolb; Isabel Deisenhofer
Journal:  Clin Res Cardiol       Date:  2018-11-20       Impact factor: 5.460

2.  Sinus Node Dysfunction after Successful Atrial Flutter Ablation during Follow-Up: Clinical Characteristics and Predictors.

Authors:  Guan-Yi Li; Fa-Po Chung; Tze-Fan Chao; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Jo-Nan Liao; Ting-Yung Chang; Ling Kuo; Cheng-I Wu; Chih-Min Liu; Shin-Huei Liu; Wen-Han Cheng; Shih-Ann Chen
Journal:  J Clin Med       Date:  2022-06-04       Impact factor: 4.964

3.  Sinus node dysfunction characterized by reduction only in maximum heart rate during exercise after superior vena cava isolation in atrial fibrillation catheter ablation-A potential complication.

Authors:  Tatsuya Hayashi; Akira Mizukami; Shunsuke Kuroda; Akihiko Matsumura; Masahiko Goya; Tetsuo Sasano
Journal:  HeartRhythm Case Rep       Date:  2020-01-09

4.  Epicardial Targets With Endocardial Ablation: Risks for the Unseen.

Authors:  Samuel J Asirvatham; Martin van Zyl; Fatima Ali-Ahmed
Journal:  JACC Case Rep       Date:  2022-09-21

5.  In silico study of the effects of anti-arrhythmic drug treatment on sinoatrial node function for patients with atrial fibrillation.

Authors:  Jieyun Bai; Yaosheng Lu; Henggui Zhang
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.